|
|
||||||||
Regular Article |
-Hydroxysteroid Dehydrogenase Genes in Late Pregnant Rats: Effect of Luteinizing Hormone and RU4861
a Laboratorio de Reproducción y Lactancia, CONICET, 5500 Mendoza, Argentina
b Department of Obstetrics, Gynecology & Reproductive Sciences, University of Saskatchewan, Saskatoon, Canada S7N 0W8
ABSTRACT
A decrease in serum progesterone at the end of pregnancy is essential for the induction of parturition in rats. We have previously demonstrated that LH participates in this process through: 1) inhibiting 3ß-hydroxysteroid dehydrogenase (3ß-HSD) activity and 2) stimulating progesterone catabolism by inducing 20
-hydroxysteroid dehydrogenase (20
-HSD) activity. The objective of this investigation was to determine the effect of LH and progesterone on the luteal expression of the steroidogenic acute regulatory protein (StAR), cytochrome P450 side-chain cleavage (P450scc), 3ß-HSD, and 20
-HSD genes. Gene expression was analyzed by Northern blot analysis 24 and 48 h after administration of LH or vehicle on Day 19 of pregnancy. StAR and 3ß-HSD mRNA levels were lower in LH-treated rats than in rats administered with vehicle at both time points studied. P450scc mRNA levels were unaffected by LH. The 20
-HSD mRNA levels were not different between LH and control rats 24 h after treatment; however, greater expression of 20
-HSD, with respect to controls, was observed in LH-treated rats 48 h after treatment. Luteal progesterone content dropped in LH-treated rats at both time points studied, whereas serum progesterone decreased after 48 h only. In a second set of experiments, the anti-progesterone RU486 was injected intrabursally on Day 20 of pregnancy. RU486 had no effect on 3ß-HSD or P450scc expression but increased 20
-HSD mRNA levels after 8 h treatment. In conclusion, the luteolytic effect of LH is mediated by a drop in StAR and 3ß-HSD expression without effect on P450scc expression. We also provide the first in vivo evidence indicating that a decrease in luteal progesterone content may be an essential step toward the induction of 20
-HSD expression at the end of pregnancy in rats.
First decision: 20 March 2001.
1 This work was supported by grant PMT-PICT0098 from Agencia Nacional de Promoción Científica y Tecnológica and by grant PLI 325/8 PRE 023/98 from the PLACIRH (Programa Latinoamericano de Capacitación e Investigación en Reproducción Humana) to C.O.S. and grants from the Natural Science and Engineering Research Council of Canada and Canadian Institute of Health Science/Saskatchewan Health Regional Partnership to J.C.
2 Correspondence: Carlos O. Stocco, Department of Physiology and Biophysics (M/C 901), University of Illinois at Chicago, 835 South Wolcott Avenue, Chicago, IL 60612-7342. FAX: 312 413 0159; costocco{at}uic.edu
3 Reprint requests: Ricardo P. Deis, Laboratorio de Reproducción y Lactancia, LARLAC-CONICET, Casilla de Correo 855, 5500 Mendoza, Argentina.
This article has been cited by other articles:
![]() |
R. Gonzalez-Fernandez, E. Martinez-Galisteo, F. Gaytan, J. A. Barcena, and J. E. Sanchez-Criado Changes in the Proteome of Functional and Regressing Corpus Luteum During Pregnancy and Lactation in the Rat Biol Reprod, July 1, 2008; 79(1): 100 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Seto-Young, D. Avtanski, M. Strizhevsky, G. Parikh, P. Patel, J. Kaplun, K. Holcomb, Z. Rosenwaks, and L. Poretsky Interactions among Peroxisome Proliferator Activated Receptor-{gamma}, Insulin Signaling Pathways, and Steroidogenic Acute Regulatory Protein in Human Ovarian Cells J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2232 - 2239. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stocco, C. Telleria, and G. Gibori The Molecular Control of Corpus Luteum Formation, Function, and Regression Endocr. Rev., February 1, 2007; 28(1): 117 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tinfo and C. Komar Potential role for peroxisome proliferator-activated receptor {gamma} in regulating luteal lifespan in the rat Reproduction, January 1, 2007; 133(1): 187 - 196. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |